Cas no 1104078-88-7 (2-methyl-2H-1,2,3-triazole-4-carbaldehyde)
2-methyl-2H-1,2,3-triazole-4-carbaldehyde Chemical and Physical Properties
Names and Identifiers
-
- 2-methyl-2H-1,2,3-triazole-4-carbaldehyde
- 2-Methyl-2H-1,2,3-triazole-4-carboxaldehyde
-
- MDL: MFCD28968295
- Inchi: 1S/C4H5N3O/c1-7-5-2-4(3-8)6-7/h2-3H,1H3
- InChI Key: ADIHVKJNUPTHMC-UHFFFAOYSA-N
- SMILES: N1=CC(C=O)=NN1C
2-methyl-2H-1,2,3-triazole-4-carbaldehyde Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | M322378-2.5mg |
2-Methyl-2H-1,2,3-triazole-4-carbaldehyde |
1104078-88-7 | 2.5mg |
$ 50.00 | 2022-06-02 | ||
| TRC | M322378-5mg |
2-Methyl-2H-1,2,3-triazole-4-carbaldehyde |
1104078-88-7 | 5mg |
$ 70.00 | 2022-06-02 | ||
| TRC | M322378-25mg |
2-Methyl-2H-1,2,3-triazole-4-carbaldehyde |
1104078-88-7 | 25mg |
$ 275.00 | 2022-06-02 | ||
| Ambeed | A118368-5g |
2-methyl-2H-1,2,3-triazole-4-carbaldehyde |
1104078-88-7 | 97% | 5g |
$4039.0 | 2024-04-26 | |
| Chemenu | CM392410-250mg |
2-methyl-2H-1,2,3-triazole-4-carbaldehyde |
1104078-88-7 | 95%+ | 250mg |
$537 | 2023-01-12 | |
| Chemenu | CM392410-500mg |
2-methyl-2H-1,2,3-triazole-4-carbaldehyde |
1104078-88-7 | 95%+ | 500mg |
$715 | 2023-01-12 | |
| Chemenu | CM392410-1g |
2-methyl-2H-1,2,3-triazole-4-carbaldehyde |
1104078-88-7 | 95%+ | 1g |
$893 | 2023-01-12 | |
| Chemenu | CM392410-5g |
2-methyl-2H-1,2,3-triazole-4-carbaldehyde |
1104078-88-7 | 95%+ | 5g |
$2620 | 2023-01-12 | |
| Chemenu | CM392410-10g |
2-methyl-2H-1,2,3-triazole-4-carbaldehyde |
1104078-88-7 | 95%+ | 10g |
$3886 | 2023-01-12 | |
| A2B Chem LLC | AV74410-2.5g |
2-methyl-2H-1,2,3-triazole-4-carbaldehyde |
1104078-88-7 | 95% | 2.5g |
$2835.00 | 2024-04-20 |
2-methyl-2H-1,2,3-triazole-4-carbaldehyde Related Literature
-
Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
-
4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
Additional information on 2-methyl-2H-1,2,3-triazole-4-carbaldehyde
Research Briefing on 2-methyl-2H-1,2,3-triazole-4-carbaldehyde (CAS: 1104078-88-7) in Chemical Biology and Pharmaceutical Applications
2-methyl-2H-1,2,3-triazole-4-carbaldehyde (CAS: 1104078-88-7) is a heterocyclic aldehyde compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a crucial building block in the synthesis of various bioactive molecules, including potential drug candidates. Its unique triazole core structure enables diverse chemical modifications, making it an attractive scaffold for medicinal chemistry and drug discovery efforts.
Recent studies have demonstrated the compound's utility in click chemistry reactions, particularly in the synthesis of triazole-containing derivatives with enhanced biological activities. The aldehyde functional group at the 4-position allows for facile conjugation with various nucleophiles, enabling the creation of diverse molecular architectures. Researchers have successfully employed this compound in the development of novel enzyme inhibitors, antimicrobial agents, and anticancer compounds, showcasing its broad potential in therapeutic applications.
In a 2023 study published in the Journal of Medicinal Chemistry, researchers utilized 2-methyl-2H-1,2,3-triazole-4-carbaldehyde as a key intermediate in the synthesis of novel kinase inhibitors. The compound's structural features allowed for efficient modification of the triazole ring system, leading to improved target binding affinity and selectivity. The resulting derivatives showed promising activity against several cancer cell lines, with IC50 values in the low micromolar range, suggesting potential for further development as anticancer agents.
Another significant application of this compound was reported in a recent ACS Chemical Biology publication, where it served as a precursor for the development of fluorescent probes targeting specific cellular proteins. The researchers leveraged the compound's reactive aldehyde group to create covalent protein-labeling probes with excellent specificity and minimal background interference. These probes have proven valuable in live-cell imaging studies and protein localization experiments.
From a synthetic chemistry perspective, recent advances have focused on developing more efficient and sustainable methods for producing 2-methyl-2H-1,2,3-triazole-4-carbaldehyde. A 2024 Green Chemistry paper described a novel catalytic system that significantly improves the yield and reduces the environmental impact of the synthesis process. These methodological improvements are crucial for scaling up production to meet the growing demand for this valuable chemical building block.
Looking forward, researchers anticipate expanding the applications of 2-methyl-2H-1,2,3-triazole-4-carbaldehyde in drug discovery and chemical biology. Ongoing studies are exploring its use in PROTAC (proteolysis targeting chimera) development, where its ability to form stable linkages between target proteins and E3 ubiquitin ligases could prove particularly valuable. Additionally, its potential in creating novel antimicrobial agents against drug-resistant pathogens represents another promising research direction.
In conclusion, 2-methyl-2H-1,2,3-triazole-4-carbaldehyde (CAS: 1104078-88-7) continues to demonstrate significant value in pharmaceutical research and chemical biology. Its versatile reactivity, combined with the biological relevance of triazole-containing compounds, ensures its continued importance in medicinal chemistry. As synthetic methods improve and new applications emerge, this compound is likely to remain a focus of research efforts in the coming years.
1104078-88-7 (2-methyl-2H-1,2,3-triazole-4-carbaldehyde) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)